» Articles » PMID: 940955

Disposition Kinetics of Dihydroquinidine Following Quinidine Administration

Overview
Date 1976 Jun 1
PMID 940955
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The disposition kinetics of dihydroquinidine, a known impurity in drug grade quinidine, was studied in 7 patients who were hospitalized for control of cardiac arrhythmias. Quinidine gluconate injection containing 5.4 to 6.2 percent dihydroquinidine was used. Following an overnite fast, dihydroquinidine doses of 0.16 to 0.31 mg/kg base were infused intravenously over 22 min. Plasma samples were collected at various times for 12 hr and analyzed for dihydroquinidine by a thin layer chromatography-fluorometric assay procedure. Postinfusion plasma dihydroquinidine concentration decline was described by a biexponential equation which suggested that the impurity distributes within the body in two kinetically distinguishable pools. The volume of the central pool (Vc) and steady-state volume of distribution (Vdss) were 0.67 +/- 0.15 L/kg and 2.76 +/- 0.63 L/kg, respectively. The halflife of the fast (t1/2alpha) and slow (t1/2beta) disposition processes were 4.71 +/- 0.26 min and 5.71 +/- 1.00 hr. Total plasma clearance was 4.17 +/- 0.68 ml/min/kg. Renal excretion of intact dihydroquinidine accounted for 16 percent of the administered dose. The corresponding value for renal dihydroquinidine clearance (Clr) was 0.61 +/- 0.08 ml/min/kg. The results of this study indicated that there were no significant differences in the distribution and elimination characteristics of dihydroquinidine and quinidine.

Citing Articles

Absorption of quinidine and dihydroquinidine in humans.

Hailey D, Lea A, Coles D, Heaume P, Smith W Eur J Clin Pharmacol. 1981; 21(3):195-9.

PMID: 7318878 DOI: 10.1007/BF00627920.


Therapeutic drug monitoring of antiarrhythmic agents.

Brown J, SHAND D Clin Pharmacokinet. 1982; 7(2):125-48.

PMID: 7039925 DOI: 10.2165/00003088-198207020-00003.


Clinical pharmacokinetics of quinidine.

Ochs H, Greenblatt D, Woo E Clin Pharmacokinet. 1980; 5(2):150-68.

PMID: 6988137 DOI: 10.2165/00003088-198005020-00003.


Pharmacokinetics of hydroxy-3(S)-dihydroquinidine in healthy volunteers after intravenous and oral administration.

Jaillon P, Poirier J, Lecocq B, Jarreau C, PAYS M, Richard M Eur J Drug Metab Pharmacokinet. 1986; 11(3):233-8.

PMID: 3816879 DOI: 10.1007/BF03189851.


Comparison of the effectiveness of dihydroquinidine and quinidine on ventricular ectopy after acute and chronic administration.

Chimienti M, Regazzi M, La Rovere M, Salerno J, Previtali M, Montericcio V Cardiovasc Drugs Ther. 1988; 2(5):679-86.

PMID: 2484920 DOI: 10.1007/BF00054209.